Haemonetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.

CEO

Christopher A. Simon

CEOChristopher A. Simon

Employees

3,009

Employees3,009

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1971

Founded1971

Employees

3,009

Employees3,009

HAE Key Statistics

Market cap

4.33B

Market cap4.33B

Price-Earnings ratio

44.55

Price-Earnings ratio44.55

Dividend yield

—

Dividend yield—

Average volume

888.76K

Average volume888.76K

High today

$92.25

High today$92.25

Low today

$89.91

Low today$89.91

Open price

$91.70

Open price$91.70

Volume

743.10K

Volume743.10K

52 Week high

$92.25

52 Week high$92.25

52 Week low

$47.32

52 Week low$47.32

Stock Snapshot

Haemonetics(HAE) stock is priced at $90.38, giving the company a market capitalization of 4.33B. It carries a P/E multiple of 44.55.

During the trading session on 2026-08-13, Haemonetics(HAE) shares reached a daily high of $92.25 and a low of $89.91. At a current price of $90.38, the stock is +0.5% higher than the low and still -2.0% under the high.

Trading volume for Haemonetics(HAE) stock has reached 743.1K, versus its average volume of 888.76K.

Over the past 52 weeks, Haemonetics(HAE) stock has traded between a high of $92.25 and a low of $47.32.

HAE News

Simply Wall St 2d

Does Strong Q1 Results And VASCADE Data Shift The Bull Case For Haemonetics?

In early August 2026, Haemonetics Corporation reported first‑quarter sales of US$339.38 million versus US$321.39 million a year earlier, with diluted earnings p...

TipRanks 4d

Haemonetics Lifts Outlook on Broad-Based Earnings Strength

Haemonetics ((HAE)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with TipR...

Simply Wall St 5d

Is Haemonetics Undervalued As Q1 Earnings And Outlook Lift Optimism?

Advertisement Why Haemonetics Stock Is Back in Focus After Q1 Earnings Haemonetics (HAE) has attracted fresh attention after first quarter revenue of US$339.3...

Analyst ratings

67%

of 12 ratings

Buy

66.7%

Hold

33.3%

Sell

More HAE News

Simply Wall St 6d

Haemonetics Stock Extends Run As Cash Flow Strength Meets Margin Pressure

Haemonetics stock came into this quarter on a tear, with shares up almost 60% over the past three months and another 3.3% added today. That kind of move sets a...

TipRanks 7d

Haemonetics price target raised to $96 from $88 at Baird

Baird raised the firm’s price target on Haemonetics (HAE) to $96 from $88 and keeps an Outperform rating on the shares. The firm updated its model following big...

Nasdaq 7d

Haemonetics Corp Q1 Sales Increase

(RTTNews) - Haemonetics Corp (HAE) reported a profit for first quarter of $33.01 million The company's earnings came in at $33.01 million, or $0.72 per share....

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.